Donald Trump stated that U.S. medical device manufacturer Becton, Dickinson and Company (BD) has agreed to invest $3 billion to localize the production of essential medical products such as syringes, needles, and laboratory kits in the United States. Of this, over $1 billion will be allocated to expansion in Nebraska to increase the output of various products, including needles made from U.S. steel. Trump attributed this to his tough medical device tariff policy, which is set to take effect before the end of this year.